{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T09:52:19Z","timestamp":1793267539232,"version":"4.5.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0220265","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T13:24:48Z","timestamp":1575984288000},"page":"e0220265","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":132,"title":["The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0981-0758","authenticated-orcid":true,"given":"Ian A.","family":"Critchley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Cotroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Pucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"issue":"sup1","key":"pone.0220265.ref001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/1120009X.2017.1380395","article-title":"Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review","volume":"29","author":"A Mazzariol","year":"2017","journal-title":"J Chemother"},{"issue":"8","key":"pone.0220265.ref002","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1128\/AAC.46.8.2540-2545.2002","article-title":"Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States","volume":"46","author":"JA Karlowsky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"pone.0220265.ref003","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1128\/AAC.00405-16","article-title":"Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014","volume":"60","author":"HS Sader","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pone.0220265.ref004","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.281.8.736","article-title":"Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women","volume":"281","author":"K Gupta","year":"1999","journal-title":"JAMA"},{"issue":"5","key":"pone.0220265.ref005","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02236-16","article-title":"Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System","volume":"61","author":"HJ Morrill","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"pone.0220265.ref006","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"K Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"pone.0220265.ref007","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"JD Pitout","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"pone.0220265.ref008","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/319757","article-title":"Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes","volume":"32","author":"E Lautenbach","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0220265.ref009","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1128\/AAC.49.5.2137-2139.2005","article-title":"High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"49","author":"MJ Schwaber","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"pone.0220265.ref010","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1128\/AAC.00155-06","article-title":"Antibiotic coresistance in extended-spectrum-beta-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline","volume":"50","author":"MI Morosini","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"pone.0220265.ref011","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/cid\/ciu864","article-title":"Emerging Escherichia coli O25b\/ST131 clone predicts treatment failure in urinary tract infections","volume":"60","author":"F Can","year":"2015","journal-title":"Clin Infect Dis"},{"key":"pone.0220265.ref012","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jgar.2015.10.006","article-title":"The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli","volume":"4","author":"F Can","year":"2016","journal-title":"J Glob Antimicrob Resist"},{"issue":"11","key":"pone.0220265.ref013","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/AAC.00576-07","article-title":"First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system","volume":"51","author":"JS Lewis","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pone.0220265.ref014","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1128\/AAC.01896-13","article-title":"Contemporary diversity of \u03b2-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent \u03b2-lactamase groups","volume":"58","author":"M Castanheira","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"pone.0220265.ref015","doi-asserted-by":"crossref","first-page":"ofx089","DOI":"10.1093\/ofid\/ofx089","article-title":"The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011\u20132012)","volume":"4","author":"JR Johnson","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"pone.0220265.ref016","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.10609.1","article-title":"Escherichia coli ST131: a multidrug-resistant clone primed for global domination","volume":"6","author":"JD Pitout","year":"2017","journal-title":"F1000Res"},{"issue":"12","key":"pone.0220265.ref017","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/cid\/ciw193","article-title":"The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts","volume":"62","author":"JR Johnson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0220265.ref018","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/cid\/ciy523","article-title":"The Uropathogenic Escherichia coli Subclone Sequence Type 131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic","volume":"68","author":"V Tchesnokova","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"pone.0220265.ref019","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.clinthera.2013.03.022","article-title":"Antimicrobial susceptibility of inpatient urinary tract isolates of gram-negative bacilli in the United States: results from the study for monitoring antimicrobial resistance trends (SMART) program: 2009\u20132011","volume":"35","author":"SK Bouchillon","year":"2013","journal-title":"Clin Ther"},{"issue":"3","key":"pone.0220265.ref020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.diagmicrobio.2013.03.032","article-title":"Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007\u20132009 SENTRY Antimicrobial Surveillance Program","volume":"76","author":"RM Kaiser","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"pone.0220265.ref021","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01045-17","article-title":"Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016","volume":"61","author":"HS Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"pone.0220265.ref022","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1093\/ofid\/ofz004","article-title":"Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of beta-lactamase Resistance Genes and Lineage Background in the United States","volume":"6","author":"RE Mendes","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"pone.0220265.ref023","unstructured":"Clinical Laboratory Standards Institute. M100-S18. Performance Standards for Antimicrobial Susceptibility Testing. 28th Edition. Wayne, Pennsulvania 2018."},{"key":"pone.0220265.ref024","article-title":"Evaluation of Antimicrobial Effects of a New Polymyxin Molecule (SPR741) When Tested in Combination with a Series of beta-Lactam Agents Against a Challenge Set of Gram-Negative Pathogens","author":"RE Mendes","year":"2019","journal-title":"Microb Drug Resist"},{"issue":"7","key":"pone.0220265.ref025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00160-19","article-title":"Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum beta-Lactamases from U.S. Hospitals","volume":"63","author":"M Castanheira","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"pone.0220265.ref026","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.cmi.2018.03.038","article-title":"Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun","volume":"24","author":"BW Trautner","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"pone.0220265.ref027","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cmi.2017.12.026","article-title":"Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study","volume":"24","author":"AJ Stewardson","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"pone.0220265.ref028","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/AAC.02505-15","article-title":"Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?","volume":"60","author":"MR Bidell","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"pone.0220265.ref029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4137\/IDRT.S13820","article-title":"Antimicrobial Susceptibility Profile of Extended Spectrum beta-Lactamase (ESBL) Producing Escherichia coli from Various Clinical Samples","volume":"7","author":"D Kumar","year":"2014","journal-title":"Infect Dis (Auckl)"},{"issue":"15","key":"pone.0220265.ref030","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1073\/pnas.1322678111","article-title":"Global dissemination of a multidrug resistant Escherichia coli clone","volume":"111","author":"NK Petty","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pone.0220265.ref031","doi-asserted-by":"crossref","first-page":"e46547","DOI":"10.1371\/journal.pone.0046547","article-title":"The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities","volume":"7","author":"S Vimont","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"pone.0220265.ref032","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/JCM.02069-13","article-title":"Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection","volume":"52","author":"F Toval","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"39","key":"pone.0220265.ref033","doi-asserted-by":"crossref","first-page":"15530","DOI":"10.1073\/pnas.1315203110","article-title":"Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation","volume":"110","author":"DJ Schwartz","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pone.0220265.ref034","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/320532","article-title":"Resistance to trimethoprim-sulfamethoxazole","volume":"32","author":"P Huovinen","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"2","key":"pone.0220265.ref035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1099\/jmm.0.000901","article-title":"Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK","volume":"68","author":"JL Cottell","year":"2019","journal-title":"J Med Microbiol"},{"issue":"2","key":"pone.0220265.ref036","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/jinf.2002.1091","article-title":"A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection","volume":"46","author":"DJ Farrell","year":"2003","journal-title":"J Infect"},{"issue":"2","key":"pone.0220265.ref037","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae","volume":"31","author":"J Rodriguez-Bano","year":"2018","journal-title":"Clin Microbiol Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220265","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T13:25:16Z","timestamp":1575984316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0220265"}},"subtitle":[],"editor":[{"given":"Adriano Gianmaria","family":"Duse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0220265","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/703199","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]}}}